Wockhardt group Founder Chairman Dr Habil Khorakiwala bags Lifetime Achievement Award at 10th IHW summit in Dubai

Mumbai: Founder Chairman of Wockhardt group, Dr Habil Khorakiwala was presented the Lifetime Achievement Award at the 10th Integrated Health & Wellbeing (IHW) Summit, a premier think-tank council engaged in public health advocacy and focused on promoting health, wellness and holistic well-being.

The esteemed advisory board recognized the exceptional contributions and lifelong dedication of Dr. Habil Khorakiwala to transform the healthcare landscape in India and globally. The IHW Council in its statement lauded his visionary leadership as the Founder Chairman of Wockhardt which has been pivotal in advancing healthcare accessibility and quality.

The Council acknowledged his unparalleled contributions towards unwavering commitment to innovation, patient care and integration of global standards setting a new benchmark in the industry.

On his behalf, the award was accepted by Dr. Huzaifa Khorakiwala (Executive Director of Wockhardt and CEO of Wockhardt Foundation) at the 10th edition of Integrated Health and Wellbeing Summit & Global Health Leaders Awards held on 21st September, 2024, at the Hyatt Regency in Deira Dubai.

Under the leadership of Dr. Habil Khorakiwala over the period of 25 years, Wockhardt has focused its research efforts in the area of discovering novel medicines for multi-drug resistant infections. This has resulted in a portfolio of 6 novel antibiotics at various stages of clinical development and commercialization, each have been granted Qualified Infectious Disease Product status by the US FDA.

Wockhardt’s novel mechanism-based antibiotic, Zaynich (Zidebactam/Cefepime), designed to target extremedrug resistant Gram negative infections, is undergoing a global Phase 3 study. Zaynich is also being evaluated in a clinical study involving patients with documented meropenem-resistant infections. Dr Habil Khorakiwala is also ex-President of FICCI & has played an important role in India’s bilateral relations & nation building effort, according to a release.

Wockhardt is a research based Global Pharmaceutical and Biotech company.

Read also: Wockhardt Chairman Dr Habil Khorakiwala conferred with BIRAC Innovator Award 2024